* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected to
show a rise in quarterly revenue when it reports results on May
6.
* The Moorestown, New Jersey-based company is expected to report
a 4.6% increase in revenue to $76.151 million from $72.83
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Tabula Rasa HealthCare
Inc is for a loss of 9 cents per share. For the same quarter
last year, the company reported earnings of 1 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 13.7% in the last three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $43, about 8.6% below its last closing price
of $46.71.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.10 -0.10 -0.08 Beat 17.2
Sep. 30 2020 0.05 0.04 -0.01 Missed -123.9
Jun. 30 2020 0.08 0.06 0.07 Beat 25.4
Mar. 31 2020 -0.03 -0.05 0.01 Beat 120.8
Dec. 0.04 0.04 0.13 Beat 251.4
31 2019
Sep. 30 2019 0.18 0.17 0.22 Beat 29.3
Jun. 30 2019 0.08 0.06 0.35 Beat 480.4
Mar. 31 2019 0.08 0.08 0.10 Beat 21.6
This summary was machine generated May 4 at 22:20 GMT. All
figures in US dollars unless otherwise stated